The Association of the British Pharmaceutical Industry (ABPI) is a trade association that represents innovative research-based pharmaceutical companies in the UK. Its members include small, medium and large pharmaceutical companies who invest heavily in research and development, bringing new, innovative medicines to patients.
ABPI works with its members to ensure that patients in the UK have access to the most innovative and effective medicines possible. It does this by engaging with policy makers, regulators and the NHS to ensure that the environment for pharmaceutical research and development in the UK is supportive and conducive to innovation.
The organization has a range of services and support resources for its members, including an extensive network of experts in the fields of drug discovery and development, as well as a comprehensive database of clinical trials. ABPI also provides its members with a range of training courses, seminars and workshops to keep them up-to-date on the latest developments in the industry.
ABPI’s mission is to improve the health of patients in the UK by enabling the discovery and development of medicines that make a real difference to their lives. This is reflected in its ongoing partnerships with charities and patient groups to ensure that the voice of patients is heard and understood within the industry.
Overall, the ABPI is a highly respected organization that plays a vital role in the UK pharmaceutical industry. Its commitment to innovation and improving healthcare for patients in the UK makes it an essential resource for pharmaceutical companies, policy makers and patients alike.
Below is a list of all of the latest articles on the ABPI brought to you by European Pharmaceutical Manufacturer.